These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 5158649)

  • 1. [Experiences with a new xanthine derivative in central and peripheral blood circulation disorders].
    Hirsch W; Woschée GJ
    Ther Ggw; 1971 Nov; 110(11):1668 passim. PubMed ID: 5158649
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences with Trental in peripheral circulatory disorders and cerebrovascular insufficiency (author's transl)].
    Schafé MK
    Munch Med Wochenschr; 1973 Oct; 115(40):1745-9. PubMed ID: 4801042
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of peripheral arterial circulation disorders using 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
    Denck H
    Arzneimittelforschung; 1973 Apr; 23(4):571-3. PubMed ID: 4740236
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the treatment of cerebral nutrition disorders. A double blind study].
    Kirchberger F; Kehl R; Gutmann W
    Med Welt; 1969 Jul; 27():1542-6. PubMed ID: 4895204
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ophthalmological experiences with the xanthine compound BL 191 (author's transl)].
    Heinsius E; Flamm P
    Med Klin; 1973 Nov; 68(47):1540-8. PubMed ID: 4781096
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental investigations on drug induced improvement of brain metabolism].
    Köhler W
    Wien Klin Wochenschr; 1972 May; 84(21):340-3. PubMed ID: 5064086
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of peripheral and cerebral circulation disorders. Experiences with bencyclan-hydrogenfumarate (Fludilat)].
    Frercks J
    Munch Med Wochenschr; 1971 Oct; 113(40):1293-8. PubMed ID: 5171108
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of xanthinol nicotinate on the small blood vessels.
    Davis E; Rozov H
    Bibl Anat; 1973; 11():334-9. PubMed ID: 4789059
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the therapy of central and peripheral blood circulation disorders].
    Weihrauch H
    Hippokrates; 1967 Sep; 38(18):739-42. PubMed ID: 5610064
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience with Complamin in peripheral circulation disorders].
    Wittenburg H
    Med Monatsschr; 1969 Dec; 23(12):558-61. PubMed ID: 5387170
    [No Abstract]   [Full Text] [Related]  

  • 11. [Demonstration of the effect of pentoxyphylline in arterial circulation disorders (double-blind study using Trental 400)].
    Schubotz R
    Med Welt; 1975 Oct; 26(41):1884-5. PubMed ID: 1196082
    [No Abstract]   [Full Text] [Related]  

  • 12. [Angiocyclan in the treatment of vascular diseases. Controlled clinical results].
    Bracale GC; Renda A
    Minerva Cardioangiol; 1975 Mar; 23(3):170-6. PubMed ID: 1128768
    [No Abstract]   [Full Text] [Related]  

  • 13. [Test of active vasodilatation in the evaluation of peripheral regional circulation in sclerotic and diabetic arteriopathies].
    Dughera L; Macchioni P; Di Leo M; Nosenzo C
    Minerva Cardioangiol; 1972 Sep; 20(9):484-96. PubMed ID: 5071470
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the treatment of cerebral and peripheral vascular disorders in general practice].
    Glashoff E
    Ther Ggw; 1969 Jan; 108(1):88-95. PubMed ID: 5763821
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of ischemic brain lesions].
    Eichhorn O
    Med Welt; 1969 Oct; 42():2314-8. PubMed ID: 4982284
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experience with a new peripheral vasodilator agent, in which are combined raubasine, and 2 ergot alkaloids in the treatment of peripheral diabetic angiopathy].
    Martínez-López JM; Calvo-Fernández R; Garrido-Toro A; Sánchez-Cañaveral F
    Angiologia; 1973; 25(4):195-8. PubMed ID: 4717702
    [No Abstract]   [Full Text] [Related]  

  • 17. [Blood viscosity and diabetes mellitus].
    Grigoleit HG; Lehrach F
    Med Monatsschr; 1973 Aug; 27(8):353-6. PubMed ID: 4756296
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical evaluation of the activity of buflomedil in ischemic processes in the legs].
    Savagnone E; Sunseri V
    Minerva Cardioangiol; 1985 Nov; 33(11):757-64. PubMed ID: 4088478
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic results with the cerebral vasodilator agent Instenon].
    Salomon K
    Wien Klin Wochenschr; 1967 Jun; 79(26):546-8. PubMed ID: 5585427
    [No Abstract]   [Full Text] [Related]  

  • 20. [The therapy of peripheral circulatory disorders (angiooganopathies) with a blood extract].
    Schirren C; Dietrich K; Biel F
    Hautarzt; 1967 Jun; 18(6):260-4. PubMed ID: 5593511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.